Fluorinated HIV-1 Protease Inhibitors Containing Chiral Hydroxyethylbenzene and Indanol as P2′ Ligands with Potent Activity Against Drug-Resistant Variants含手性羟乙基苯和吲哚醇作为P2′配体的氟化HIV-1蛋白酶抑制剂，对耐药变异体具有显著活性European Journal of Medicinal ChemistryIF5.92025-12-190PRE
HIV-1 protease inhibitors with a P1 phosphonate modification maintain potency against drug-resistant variants by increased interactions with flap residuesEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92023-09-015OAAI
Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-tetrahydrofuran in a Pseudosymmetric Dipeptide IsostereJOURNAL OF MEDICINAL CHEMISTRYIF6.82020-07-166OAAI
HIV-1 Protease Inhibitors Incorporating Stereochemically Defined P2′ Ligands To Optimize Hydrogen Bonding in the Substrate EnvelopeJOURNAL OF MEDICINAL CHEMISTRYIF6.82019-08-0624OAAI
Structural Adaptation of Darunavir Analogues against Primary Mutations in HIV-1 Protease (vol 5, pg 316, 2019)ACS INFECTIOUS DISEASESIF3.82019-04-162OAAI
Structural Adaptation of Darunavir Analogues against Primary Mutations in HIV-1 ProteaseACS INFECTIOUS DISEASESIF3.82018-12-1327OAAI
Quinoxaline-Based Linear HCV NS3/4A Protease Inhibitors Exhibit Potent Activity against Drug Resistant VariantsACS MEDICINAL CHEMISTRY LETTERSIF42018-05-1719OAAI
Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime SideJOURNAL OF VIROLOGYIF3.82017-05-1548OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向